The stock has more than doubled in three months and is up by more than 81 per cent in one year. In past one month alone the stock has gained by more than 51 per cent and is catching investors’ attention.

The stock opened the session with marginal gains but soon after that, it began to move higher and that too, with a spike in volumes. The stock made a high of Rs 62.15 and gained as much as 15 per cent at the high of the day.

Lupin Limited has received approval for its Sevelamer Hydrochloride tablets, 400 mg & 800 mg from United States Food & Drug Administration (USFDA) to market a generic equivalent of Renagel tablets, 400 mg & 800 mg, of Genzyme Corporation. The product will be manufactured at Lupin’s facility in Nagpur (Maharashtra). 

Learn about the concept of Meme stocks and why investors are rushing to invest in them.

Going hand in hand with the overall positive sentiments in the domestic stock markets in June 2021, a number of low-scrip stocks caught investors’ attention as well.

On one hand, many analysts are worried about the bubbling of stock market bubble while on the other hand, some are extremely optimistic about the bull run. Even then, June 2021 has been an interesting month for domestic stock markets as penny stocks seem to be back in action.  

Marico along with Tata consumer products, UBL and Nestle are contributing the most to the index gains. UBL is up by more than 2 per cent while Nestle gained nearly 1 per cent.

The market opened in red on June 17, 2021.

The market opened in red on June 17, 2021, overall volumes in futures & options currently stand at 4,52,48,287 contracts with a turnover of Rs. 44,28,511.46 crore.

The market opened in red on June 17, 2021, overall volumes in futures & options currently stand at 4,52,48,287 contracts with a turnover of Rs. 44,28,511.46 crore.